Crowdonomics
All companies
CANINE BIOLOGICS logo

CANINE BIOLOGICS

Operating

Canine Life Sciences Inc.

Retail & Consumer · Founded 2019

Our 2021 expansion brings breakthrough nutrition to more dogs with cancer

Post-money valuation ⓘ
$6.2M
As of Apr 2022 · from Reg CF Offering (2021-09-12) · pre-money + amount raised, not a traded price
Total raised
$96,712
Across 2 rounds since 2021
Latest share price
$0.81
Reg CF · Common Stock · Sep 2021 offering price

Financials

FY2019–FY2022 · from SEC filings · hover any figure for its source
$0
−$10K
2019
2020
$6K
−$354K
2021
$49K
−$449K
2022
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019 reviewed
FY2020 reviewed
FY2021 unaudited
FY2022 unaudited
Income statement
Revenue
$0
—
$5,823
$49,391
Cost of goods sold
$0
—
$5,650
$72,559
Gross margin
—
—
3%
-47%
Net income
-$10,497
—
-$353,517
-$449,310
Taxes paid
$0
—
$0
$0
Balance sheet
Cash
$119,551
—
$98,886
$24,684
Accounts receivable
$0
—
$25,894
$11,110
Total assets
$146,911
—
$404,133
$159,970
Short-term debt
$8,409
—
$19,100
$66,000
Long-term debt
$0
—
$0
$0
Total liabilities
$8,409
—
$19,100
$66,000
Other
Headcount
—
5
—
5

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$6.5M
Valuation cap
$6.1M
pre-money
Reg CF · SAFE · May 2021
Reg CF · Common · Sep 2021

Blue bars are the pre-money valuation the company stated for a priced round. Dashed amber bars are a SAFE or convertible note's valuation cap — the most it converts at, not what the company is worth, so don't compare them with the other bars.

Fundraising history

Raised $39.1K / $477.5KPost-money $6.2M
Reg CF · SAFE · May 2021Closedvia WeFunder
Raised $57.6K / $1.1MInvestors 26Valuation cap $6.5M

Team

2 people
Charles Mueller
Principal Financial Officer
Jeff Sutherland
Principal Executive Officer

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFewer than 300 holders of record

Filed 1 of 5 annual reports (FY2021–FY2025)

26 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-ARMar 21, 20220001669191-22-000235
    EDGAR
  • Form C-UMar 17, 20220001669191-22-000233
    EDGAR
  • Form C/ANov 19, 20210001669191-21-001148
    EDGAR
  • Form C/AOct 1, 20210001669191-21-001002
    EDGAR
  • Form C/ASep 24, 20210001669191-21-000955
    EDGAR
  • Form C/ASep 10, 20210001669191-21-000875
    EDGAR
  • Form CSep 9, 20210001669191-21-000873
    EDGAR
  • Form CMay 5, 20210001670254-21-000639
    EDGAR
Source: ManualCIK 0001857342Share price $0.81

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.